Maja Kuklo

Maja Kuklo

Auto-generated profile, based on publicly available information

Maja Kuklo

Clinical Hospital of the Ministry of Internal Affairs and Administration with the Warmia-Mazury Oncology Centre in Olsztyn, Olsztyn, Poland

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
BGBartłomiej Grodziński
Bartłomiej Grodziński
DŁDominik Łepecki
Dominik Łepecki
WDWiktoria Natalia Dzierzgowska
Wiktoria Natalia Dzierzgowska
MNMartyna Niemczuk
Martyna Niemczuk
MKMateusz Korga
Mateusz Korga
AKAgata Karasiewicz
Agata Karasiewicz
Chronic Kidney Disease (CKD) is a significant global health issue characterized by progressive loss of kidney function, impacting quality of life and increasing the risk of morbidity and mortality. This paper explores the multifaceted role of physical activity in managing CKD, focusing on its benefits, safety considerations, and best practices for exercise prescription, based on systematic reviews of literature sourced from PubMed and Google Scholar. While physical activity has been shown to offer substantial benefits, such as improved cardiovascular outcomes, enhanced physical function, and reduced inflammation, safety concerns are paramount. These include potential risks associated with exercise intensity and its effects on kidney function and overall health. The paper also evaluates best practices for integrating exercise into CKD management, based on recent evidence and expert recommendations. Our findings suggest that regular physical activity is a crucial component of CKD management, with significant potential to improve patient outcomes. However, tailored exercise programs that account for individual patient conditions and disease stages are essential to maximize benefits and minimize risks. This review underscores the need for ongoing research and refined guidelines to optimize exercise interventions for CKD patients, ensuring safe and effective integration into standard care practices.

2 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
AKAleksandra Karolak
Aleksandra Karolak
JLJakub Michał Lichoń
Jakub Michał Lichoń
MGMateusz Józef Goldyn
Mateusz Józef Goldyn
EWEwa Wietrzykowska
Ewa Wietrzykowska
PTPiotr Trojan
Piotr Trojan
MKMarta Kras
Marta Kras
Introduction: Bruxism is currently understood as a range of jaw muscle activities and teeth contact that occur during sleep and/or wakefulness. Awake bruxism can be distinguished from sleep bruxism based on differences in etiology, comorbidities, and the spectrum of muscle activity and clinical manifestations. Although the exact cause of bruxism remains unclear, it is considered to be multifactorial. This article aims to highlight both awake and bruxism and explore various approaches to their management. Aim of the Study: The aim of this article is to review current knowledge on awake and sleep bruxism and increase awareness of its multidisciplinary management. Materials and Methods: A literature review was conducted using the PubMed and Google Scholar databases. The following keywords were used in various combinations: "bruxism," "awake," "sleep" "management," "treatment," and "oral health." Fourty four relevant articles published between 2001 and 2025 were selected for analysis. Results: The most common current approaches to managing awake and sleep bruxism include occlusal splints, mandibular advancement devices, cognitive-behavioral therapy (CBT), biofeedback therapy, mindfulness techniques, self-awareness and self-regulation strategies, physical therapy (such as physiotherapy, exercise, and dry needling), botulinum toxin injections, and non-steroidal anti-inflammatory drugs (NSAIDs) for pain exacerbation. Conclusion: Bruxism and its associated symptoms can significantly affect patients' quality of life. Early identification and appropriate management can help reduce facial muscle soreness, headaches, and general fatigue and pathological tooth wear.

20 February 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MGMateusz Józef Gołdyn
Mateusz Józef Gołdyn
JLJakub Michał Lichoń
Jakub Michał Lichoń
MKMarta Kras
Marta Kras
AKAgata Karasiewicz
Agata Karasiewicz
MKMaja Kuklo
Maja Kuklo
EJEliza Jakubowska
Eliza Jakubowska
Non-medical use of anabolic-androgenic steroids (AAS) has expanded beyond elite sports and is common among recreational strength trainees. Chronic supraphysiologic exposure is associated with adverse cardiovascular (CV) remodeling, accelerated atherosclerosis, and excess mortality. This review synthesizes evidence on AAS-associated CV toxicity and proposes a pragmatic diagnostic approach. Current data describe distinct clinical features in users: (i) often reversible cardiometabolic disturbances (dyslipidaemia, hypertension), (ii) structural remodeling, notably concentric left ventricular hypertrophy, (iii) impaired global longitudinal strain that can persist years after cessation, and (iv) premature coronary plaque burden linked to cumulative lifetime exposure. Furthermore, cardiac PET/CT studies indicate persistent coronary microvascular dysfunction, while registry cohorts confirm increased CV disease rates. Consequently, AAS use should be considered a major, under-recognized CV risk factor. We propose a phenotype-based assessment integrating non-judgmental history-taking, athlete-specific ECG interpretation, echocardiography with strain, and selective use of CMR and CCTA. Management should prioritize cessation support, harm reduction, and guideline-directed therapy tailored to the specific clinical phenotype (e.g., cardiomyopathy or coronary disease).

9 February 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MKMarta Kras
Marta Kras
AKAgata Karasiewicz
Agata Karasiewicz
MKMaja Kuklo
Maja Kuklo
DŁDominik Łepecki
Dominik Łepecki
AKAleksandra Karolak
Aleksandra Karolak
PTPiotr Trojan
Piotr Trojan
Sport-related injuries have been reported as one of the top three causes of nasal bone fractures in the paediatric population regardless of the region. The most common sport disciplines responsible for nasal bone fractures are ball games like football, basketball and baseball. The diagnosis of nasal bone fracture is especially difficult in children consequential to a different anatomical structure of their nose than that of an adult’s. Masked by edema etc it is frequent for a paediatric fracture to be omitted on first examination, therefore it is crucial for physicians to take history and examine the young patients very carefully despite the child’s potential non-cooperative spirit. Paediatric nasal fractures are most commonly managed with closed reduction as surgical treatment is often delayed until the nose's development is complete, which occurs around adolescence, in order to avoid interfering with the growth centre. This approach may result in various post-traumatic complications, typically requiring frequent follow-up visits and secondary surgical treatment. As a result, it is critical to pay close attention to the underlying structural nasal structure during the initial diagnosis and treatment to avoid complications such as septal hematoma, septal deviation, and nasal obstruction. This review aims to outline the most frequent and severe long-term complications, stress the significance of early diagnosis and treatment, and provide strategies for preventing nasal bone fractures both re-injury and re-injury in children. Additionally, we would like to explore the likelihood that children will experience post-traumatic nasal obstruction, which can subsequently result in sleep apnea, reduced quality of life, and impaired athletic performance.

19 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
AWAndrzej Wydrych
Andrzej Wydrych
PPPatryk Pindlowski
Patryk Pindlowski
EWEwa Wietrzykowska
Ewa Wietrzykowska
PTPiotr Trojan
Piotr Trojan
MKMaja Kuklo
Maja Kuklo
MOMichał Olkowski
Michał Olkowski
Introduction and Objective: Sleep and circadian rhythm disturbances are highly prevalent in Schizophrenia and significantly impact symptom severity, disease progression, and treatment outcomes. Schizophrenia, a chronic and disabling mental illness affecting approximately 1% of the global population, is particularly associated with pronounced sleep abnormalities. Over 80% of patients with schizophrenia experience reduced sleep efficiency and delayed sleep onset. These disturbances are closely linked to worsening psychotic symptoms, cognitive dysfunction, and diminished quality of life. This review aims to explore the role of melatonin in these disruptions and its potential as an adjunctive treatment in Schizophrenia. Materials and methods: Articles in PubMed, GoogleScholar, ScienceDirect databases were retrieved by the authors. The authors searched with keywords: melatonin, schizophrenia, sleep disorder, circadian rhythms, psychiatric disease. Articles between 2000 and 2024 were included. Results: Randomized controlled trials show that prolonged-release melatonin (2–10 mg, 1–2 hours before bedtime) improves sleep latency, efficiency, and duration in schizophrenia. Melatonin, immediate-release, has variable findings; low doses (<1 mg) are used to treat circadian disorders, while higher doses (3–12 mg) are used to treat insomnia. Melatonin will also improve benzodiazepine withdrawal insomnia and help habituate to sleep in a novel environment. It is tolerable with mild but occasional side effects, but larger, high-quality trials are needed. Conclusions: Melatonin is of great promise as an adjunct to sleep and circadian disturbance treatment in schizophrenia and related psychiatric illnesses, but more extensive research must be conducted to confirm its long-term safety and clinical efficacy.

24 February 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MGMateusz Józef Gołdyn
Mateusz Józef Gołdyn
JLJakub Michał Lichoń
Jakub Michał Lichoń
MKMarta Kras
Marta Kras
AKAgata Karasiewicz
Agata Karasiewicz
MKMaja Kuklo
Maja Kuklo
EJEliza Jakubowska
Eliza Jakubowska
Modern anesthesia is a high-frequency control problem: clinicians must continuously titrate hypnotics, opioids, fluids, and vasopressors to achieve adequate hypnosis/analgesia while avoiding hemodynamic instability and downstream organ injury. Artificial intelligence (AI), machine learning, and classical control engineering are increasingly embedded in perioperative monitors and drug delivery platforms, enabling decision support and closed-loop control. Randomized trials and meta-analyses indicate that closed-loop systems for hypnosis (typically processed EEG targets such as BIS) improve time-in-target and reduce overshoot/undershoot compared with manual titration. Multi-variable systems that co-manage hypnosis, analgesia, and fluids are feasible and may improve short-term recovery outcomes in selected settings. On the hemodynamic side, intraoperative hypotension is common and associated with myocardial and kidney injury, AI-based early warning systems using arterial waveforms can predict hypotension minutes before onset and, when paired with treatment protocols, may reduce hypotension burden in some trials. Closed-loop vasopressor and fluid systems improve protocol adherence and reduce hypotension in perioperative and early postoperative care. AI-enabled decision support and closed-loop controllers can improve stability of anesthesia and blood pressure management, but they should be implemented as supervised systems with clear safety constraints, manual override, and ongoing performance monitoring. Future multicenter trials should prioritize patient-centered outcomes, external validation, and transparent reporting.